Nvidia-backed SandboxAQ Introduces AI-Powered Medical Data to Aid Drug Development
ByAinvest
Wednesday, Jun 18, 2025 9:12 am ET1min read
NVDA--
SandboxAQ, spun out of Alphabet's Google and backed by Nvidia, has raised nearly $1 billion in venture capital [2]. The company generated about 5.2 million synthetic three-dimensional molecules using Nvidia's chips. This data can train AI models to predict whether a new drug molecule will bind to the target protein, a crucial step before advancing a drug candidate [1].
The approach combines traditional scientific computing techniques with advancements in AI, addressing a long-standing problem in biology [1]. By using synthetic data, SandboxAQ aims to provide results that rival lab experiments but in a fraction of the time [1].
The release of this data could boost Nvidia's business, particularly as demand for AI servers increases. Analysts predict a 20.17% upside for NVDA stock [3].
References:
[1] Reuters. (2025). Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery. [URL](https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3SK10Y:0-nvidia-backed-ai-startup-sandboxaq-creates-new-data-to-speed-up-drug-discovery/)
[2] Nellis, S. (2025). Nvidia-backed AI startup SandboxAQ releases data to speed up drug discovery. [URL](https://tech.yahoo.com/ai/articles/nvidia-backed-ai-startup-sandboxaq-120558861.html)
[3] Hackster.io. (2025). Nvidia's robots dream of trajectories not electric sheep with GR00T dreams. [URL](https://www.hackster.io/news/nvidia-s-robots-dream-of-trajectories-not-electric-sheep-with-gr00t-dreams-1f12db16c80f)
SAND--
Nvidia-backed SandboxAQ released new AI medical data, including details on drug connections to proteins, which can help scientists develop new medicines. The data was created using Nvidia's processors, simulating synthetic molecules based on real-world data. This could boost Nvidia's business as demand for AI servers increases, with analysts predicting a 20.17% upside for NVDA stock.
Nvidia-backed AI startup SandboxAQ has released a significant dataset aimed at speeding up the discovery of new medical treatments. The data, generated using Nvidia's processors, simulates synthetic molecules based on real-world data, helping scientists predict how drugs interact with proteins [1].SandboxAQ, spun out of Alphabet's Google and backed by Nvidia, has raised nearly $1 billion in venture capital [2]. The company generated about 5.2 million synthetic three-dimensional molecules using Nvidia's chips. This data can train AI models to predict whether a new drug molecule will bind to the target protein, a crucial step before advancing a drug candidate [1].
The approach combines traditional scientific computing techniques with advancements in AI, addressing a long-standing problem in biology [1]. By using synthetic data, SandboxAQ aims to provide results that rival lab experiments but in a fraction of the time [1].
The release of this data could boost Nvidia's business, particularly as demand for AI servers increases. Analysts predict a 20.17% upside for NVDA stock [3].
References:
[1] Reuters. (2025). Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery. [URL](https://www.tradingview.com/news/reuters.com,2025:newsml_L6N3SK10Y:0-nvidia-backed-ai-startup-sandboxaq-creates-new-data-to-speed-up-drug-discovery/)
[2] Nellis, S. (2025). Nvidia-backed AI startup SandboxAQ releases data to speed up drug discovery. [URL](https://tech.yahoo.com/ai/articles/nvidia-backed-ai-startup-sandboxaq-120558861.html)
[3] Hackster.io. (2025). Nvidia's robots dream of trajectories not electric sheep with GR00T dreams. [URL](https://www.hackster.io/news/nvidia-s-robots-dream-of-trajectories-not-electric-sheep-with-gr00t-dreams-1f12db16c80f)
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet